A detailed history of Hillsdale Investment Management Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 136,830 shares of CDNA stock, worth $2.9 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
136,830
Holding current value
$2.9 Million
% of portfolio
0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$14.41 - $33.99 $1.97 Million - $4.65 Million
136,830 New
136,830 $4.27 Million
Q4 2021

Feb 07, 2022

SELL
$41.2 - $73.6 $580,920 - $1.04 Million
-14,100 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$59.15 - $91.99 $834,015 - $1.3 Million
14,100 New
14,100 $894,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.13B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.